Sample Teaching Plan for Chronic Illness in Canada
Verified
Added on  2023/04/08
|7
|670
|359
AI Summary
This teaching plan focuses on defining the symptoms and signs of chronic illness, specifically Alzheimer's disease, in Canada. It includes objectives, teaching strategies, evaluation methods, and timeframe.
Contribute Materials
Your contribution can guide someone’s learning journey. Share your
documents today.
Running head: SAMPLE TEACHING PLAN1 STUDENT NAME: STUDENT ID: TOPIC: SAMPLE TEACHING PLAN FOR CHRONIC ILLNESS DATE: 20-3-2019
Secure Best Marks with AI Grader
Need help grading? Try our AI Grader for instant feedback on your assignments.
SAMPLE TEACHING PLAN2 Sample Teaching Plan for Chronic Illness in Canada TopicObjectivesTeaching strategy Evaluation method Timeframe A. Definition of Alzheimer’s disease B.Signsof Alzheimer’s C. Symptoms of Alzheimer’s D. Actions taken forthe preventionof Alzheimer’slike a chronic disease. The objectives of teachingchronic illness: -Todistinguish thesymptoms andsignsof Alzheimer’s. -Todemonstrate theabilityto perform treatmentfor Alzheimer’s. The objective of the teaching plan istoclearly definethe symptomsand signsof chronic diseaseandthe provisionof appropriate treatmentsto cure the disease. A presentation is preparedthat containschronic disease signs and symptoms (McKhann, et al., 2011).The presentation includespre- dementia information, cause,signs, symptoms, pathophysiology, diagnosis,and preventionof Alzheimer’s (Spinney, 2014). Theteaching strategy includes knowledge about chronicillness. Education provides knowledge about thesignsand The client needs toidentify symptomsand signswiththe rating systemon a scale of 0-10. If the score is 0, the confidenceis low, if the score is10,thereis complete confidencein workingwhile identifyingthe signsand symptoms of the disease. Therating methodisto ensurethat nurses are aware oftheconcepts andtopicsthat are discussed. Therating methodisona 10 min
SAMPLE TEACHING PLAN3 symptomsof chronic illnesses. Canadahasthe highest interaction betweennurse andpatientdue tochronic diseaseslike Diabetes, Alzheimer’s, etc. Itisimportant thattheexperts in chronic illness treatmentsfocus onattaining goalswhile identifyingthe disease and help prevent the same with medications andtreatments (Bateman, et al., 2012). Implementing effectiveplans helpstocurtail the knowledge of the cost burdens andhelpsto managechronic scale from 0-10, with 10 being the highest score that determines complete awarenessof diagnosingthe signsand symptomsof Alzheimer’sand havingcomplete confidencein treatingthe disease, which is a challenging and acritical situationthat new nurses face inhealthcare systems.
SAMPLE TEACHING PLAN4 diseases.A critical challenge istoadminister and diagnose the disease in case of signsand symptoms (Imbimbo, et al., 2012). Publicand community healthnurses must be provided withadequate educationand trainingto identifyand preventchronic illnessesin Canada.Nurses andeducators must be aware of theaspectsof disease preventionand health promotion strategies. Theteaching plan is for nurses treatingchronic illnessesin
Paraphrase This Document
Need a fresh take? Get an instant paraphrase of this document with our AI Paraphraser
SAMPLE TEACHING PLAN5 Canada.The topicof Alzheimer’s diseaseandthe relatedconcepts arediscussedin the teaching plan. Themain discussionison the definition of Alzheimer’s, signs, symptoms, actionstobe takenfor preventingthe disease,etc. (Holtzman,Herz & Bu, 2012). Theteaching strategy used is a 10-minutelong presentation, whichincludes allimportant pointsabout Alzheimer’sand itsprevention strategy(Ward, Tardiff,Dye& Arrighi, 2013).
SAMPLE TEACHING PLAN6 References
SAMPLE TEACHING PLAN7 Bateman, R.J., Xiong, C., Benzinger, T.L., Fagan, A.M., Goate, A., & Fox, N.C. (2012). Clinical andbiomarkerchangesindominantlyinheritedAlzheimer’sdisease.NEnglJ Med,367(9), 795-804. Holtzman, D.M., Herz. J., & Bu, G. (2012). Apolipoprotein E and apolipoprotein E receptors: Normal biology and roles in Alzheimer disease.Cold Spring Harb Perspect Med,2(3). Imbimbo, B.P., Ottonello, S., Frisardi, V., Solfrizzi, V., Greco, A., Seripa, D., Pilotto, A., Panza, F. (2012). Solanezumab for the treatment of mild-to-moderate Alzheimer disease. Expert Rev Clin Immunol,8(2), 49-135. McKhann, G.M., Knopman, D.S., Chertkow, H., Hyman, B.T., Jack, C.R., Kawa,s C.H. (2011). The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the NationalInstituteonAging-Alzheimer’sAssociationworkgroupsondiagnostic guidelines for Alzheimer’s disease. Alzheimers Dement,7(3), 9-263. Spinney, L. (2014). Alzheimer’s disease: The forgetting gene.Nature,510(7503), 26-81. Ward, A., Tardiff, S., Dye, C., Arrighi, H.M. (2013). Rate of conversion from prodromal Alzheimer’s disease to Alzheimer’s dementia: A systematic review of the literature. Dement Geriatr Cogn Disord Extra,3, 32-320